Photobiomodulation treatment for head and neck atopic dermatitis
resistant to Dupilumab: a case report.
- Giulia Tonini,
- Giulia Davini,
- Agata Janowska,
- Michela Iannone,
- Teresa Oranges,
- Marco Romanelli,
- Valentina Dini
Abstract
We report the case of a man affected by atopic dermatitis on dupilumab.
During the treatment, the patient showed a worsening of head and neck
dermatitis. Blue light irradiation is a safe and efficacy tool for head
and neck dermatitis persisting or developed during therapy with
dupilumab.02 Apr 2020Submitted to Clinical Case Reports 10 Apr 2020Assigned to Editor
10 Apr 2020Submission Checks Completed
22 Apr 2020Reviewer(s) Assigned
26 Apr 2020Review(s) Completed, Editorial Evaluation Pending
18 May 2020Editorial Decision: Revise Minor
